Winningham Rick E
SEC insider (Form 3/4/5 filer). CIK 0001302443. CHIEF EXECUTIVE OFFICER at Theravance Biopharma, Inc. (TBPH) and 1 other issuer. 29 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in DUBLIN 4.
Companies Winningham Rick E has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Director, Officer, CHIEF EXECUTIVE OFFICER
- Jazz Pharmaceuticals plc (JAZZ): Director
Winningham Rick E
CIK: 0001302443
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect1.4M shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect76.9K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionIndirect23.4K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect151.9K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionIndirect92.6K shares- - Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
Tax PaymentDirect14 shares at avg. $244.64$3K - Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
Tax PaymentDirect1.7K shares at avg. $241.39$408K - Aug 20, 2026TBPH
Theravance Biopharma, Inc.
Tax PaymentDirect20K shares at avg. $16.95$340K - Aug 5, 2026JAZZ
Jazz Pharmaceuticals plc
AwardDirect1.6K shares- - May 22, 2026JAZZ
Jazz Pharmaceuticals plc
SaleDirect2.7K shares at avg. $241.57$662K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  TBPH Theravance Biopharma, Inc. | Disposition | 1,382,272 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 76,875 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 23,400 | - | $0 | Indirect |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 151,875 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 92,567 | - | $0 | Indirect |
| Aug 31, 2026 |  JAZZ Jazz Pharmaceuticals plc | Tax Payment | 14 | $244.64 | $3,425 | Direct |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | Tax Payment | 1,692 | $241.39 | $408,432 | Direct |
| Aug 20, 2026 | TBPH Theravance Biopharma, Inc. | Tax Payment | 20,034 | $16.95 | $339,576 | Direct |
| Aug 5, 2026 | JAZZ Jazz Pharmaceuticals plc | Award | 1,605 | - | $0 | Direct |
| May 22, 2026 | JAZZ Jazz Pharmaceuticals plc | Sale | 2,741 | $241.57 | $662,143 | Direct |
1-10 of 29 transactions